Wanbury Limited (NSE:WANBURY)
India · Delayed Price · Currency is INR 265.00
+6.85 (2.65%)
Jun 5, 2026, 3:29 PM IST
Wanbury Market Cap
Wanbury has a market cap or net worth of 9.01 billion as of June 5, 2026. Its market cap has decreased by -1.19% in one year.
Market Cap
9.01B
Enterprise Value
11.18B
Revenue
6.51B
Ranking
n/a
PE Ratio
13.62
Stock Price
265.00
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 9.01B, an increase of 409.63%. That is a compound annual growth rate of 7.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 9.01B | 13.67% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 26.17B |
| Indoco Remedies | 19.69B |
| Sakar Healthcare | 18.09B |
| Windlas Biotech | 17.01B |
| Beta Drugs | 14.68B |
| Ind-Swift Laboratories | 13.62B |
| Jagsonpal Pharmaceuticals | 13.56B |
| Sigachi Industries | 8.19B |